
TSE:JWEL
This summary was created by AI, based on 1 opinions in the last 12 months.
Jamieson Wellness, symbol JWEL-T, has established itself as a solid player in the Canadian wellness sector, particularly noted for its high-quality products and stable growth trajectory. Founded in Windsor, Ontario, the company has expanded its footprint by acquiring a California-based firm, effectively mitigating risks associated with tariffs. With a keen focus on the burgeoning Chinese market, Jamieson's commitment to quality distinguishes it from competitors. Over the past five years, the company has impressively increased its dividend payouts at an average rate of 14%, attracting attention from investors seeking dependable income streams. At a current yield of 2.55% and with analysts projecting a price target of $42.43, there seems to be strong potential for future appreciation, reinforcing its status as an appealing option for portfolio enhancement.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. EPS at 34 cents that beat estimates by 2%. Sales of $112.3M were reported. Generally a good quarter. The focus on post covid health trends continue to be a tailwind. Attractive here. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenues beat street estimates by 4%. EBITDA was 2% better at $29M. It is trading at 26x earnings, which is reasonably considering the high growth expectations. There are competitors but they have strong market share. A higher risk buy for growth and some income. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Business has reamiend good and earnings growth continues to be expected. They raised dividends in August with more room to grow. The $6 decline is probably over done. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Sales beat expectations by 6% and earnings also beat estimates by 2%. Guidance was raised, which is also positive. The pull back that brought it down 16% is more market related than to do with the stock itself. It is a good time to add to this position. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Covid has helped the company with consumers more aware of health. They beat sale estimates last quarter but missed on EPS. It’s trading within its expected growth rate. The health trend should be sustained even after covid. Unlock Premium - Try 5i Free